HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

Published:2020-01 Issue:1 Volume:127 Page:72-84
ISSN:0161-6420
Container-title:Ophthalmology
language:en
Short-container-title:Ophthalmology

Author:

Dugel Pravin U.,Koh Adrian,Ogura Yuichiro,Jaffe Glenn J.,Schmidt-Erfurth Ursula,Brown David M.,Gomes Andre V.,Warburton James,Weichselberger Andreas,Holz Frank G.

Funder

Novartis Pharma

Publisher

Elsevier BV

Subject

Ophthalmology

Reference41 articles.

1. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA);Schmidt-Erfurth;Br J Ophthalmol,2014

2. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis;Wong;Lancet Glob Health,2014

3. Age-related macular degeneration: advances in management and diagnosis;Yonekawa;J Clin Med,2015

4. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

5. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

Cited by 622 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe Intraocular Inflammation After Intravitreal Injection of Faricimab: A Single-Site Case Series of Six Patients;American Journal of Ophthalmology;2025-01

2. Brolucizumab versus aflibercept for recalcitrant diabetic macular edema in Indian real-world scenario – The BRADIR study;American Journal of Ophthalmology Case Reports;2024-12

3. Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study;Ophthalmology Science;2024-11

4. Aqueous Humor Cytokine Analysis in Age-Related Macular Degeneration After Switching From Aflibercept to Faricimab;Investigative Ophthalmology & Visual Science;2024-09-09

5. Predictors of Disease Activity After Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration Using Real-World Data from the PROOF Study;Ophthalmology and Therapy;2024-09-05